Melvyn Lynn

2.1k total citations
30 papers, 1.1k citations indexed

About

Melvyn Lynn is a scholar working on Immunology, Epidemiology and Molecular Biology. According to data from OpenAlex, Melvyn Lynn has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Immunology, 11 papers in Epidemiology and 7 papers in Molecular Biology. Recurrent topics in Melvyn Lynn's work include Immune Response and Inflammation (17 papers), Sepsis Diagnosis and Treatment (10 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Melvyn Lynn is often cited by papers focused on Immune Response and Inflammation (17 papers), Sepsis Diagnosis and Treatment (10 papers) and Antibiotics Pharmacokinetics and Efficacy (6 papers). Melvyn Lynn collaborates with scholars based in United States, Canada and Japan. Melvyn Lynn's co-authors include Daniel P. Rossignol, Richard Kao, Steven P. LaRosa, Steven M. Opal, Jagadish Gogate, Carlos Perdomo, Robert J. Noveck, Alec E. Wittek, Darryl B. Neill and William Tillis and has published in prestigious journals such as Neuroscience, CHEST Journal and The Journal of Infectious Diseases.

In The Last Decade

Melvyn Lynn

30 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Melvyn Lynn United States 18 647 348 203 144 109 30 1.1k
David E. Newcomb United States 11 725 1.1× 483 1.4× 221 1.1× 51 0.4× 183 1.7× 14 1.3k
S E Calvano United States 16 444 0.7× 352 1.0× 227 1.1× 41 0.3× 158 1.4× 20 1.2k
Mohammed M. Sayeed United States 23 481 0.7× 411 1.2× 438 2.2× 44 0.3× 80 0.7× 60 1.4k
Robert Hageman Netherlands 11 410 0.6× 212 0.6× 259 1.3× 54 0.4× 82 0.8× 20 1.1k
Sally Betz Corradin Switzerland 18 378 0.6× 396 1.1× 307 1.5× 42 0.3× 49 0.4× 22 1.2k
Hongke Zeng China 22 225 0.3× 287 0.8× 402 2.0× 92 0.6× 171 1.6× 77 1.3k
Michela Rebsamen Switzerland 13 355 0.5× 90 0.3× 297 1.5× 132 0.9× 71 0.7× 16 1.3k
David Cruz‐Robles Mexico 17 184 0.3× 248 0.7× 280 1.4× 108 0.8× 54 0.5× 50 1.3k
Hong‐Beom Bae South Korea 20 538 0.8× 236 0.7× 684 3.4× 65 0.5× 134 1.2× 59 1.5k
Judy A. Spitzer United States 17 257 0.4× 170 0.5× 181 0.9× 41 0.3× 61 0.6× 51 816

Countries citing papers authored by Melvyn Lynn

Since Specialization
Citations

This map shows the geographic impact of Melvyn Lynn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melvyn Lynn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melvyn Lynn more than expected).

Fields of papers citing papers by Melvyn Lynn

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melvyn Lynn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melvyn Lynn. The network helps show where Melvyn Lynn may publish in the future.

Co-authorship network of co-authors of Melvyn Lynn

This figure shows the co-authorship network connecting the top 25 collaborators of Melvyn Lynn. A scholar is included among the top collaborators of Melvyn Lynn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melvyn Lynn. Melvyn Lynn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kalil, André C., Steven P. LaRosa, Jagadish Gogate, Melvyn Lynn, & Steven M. Opal. (2011). Influence of Severity of Illness on the Effects of Eritoran Tetrasodium (E5564) and on Other Therapies for Severe Sepsis. Shock. 36(4). 327–331. 28 indexed citations
2.
Francis, Gordon A., et al.. (2011). Deactivation of the lipopolysaccharide antagonist eritoran (E5564) by high-density lipoprotein-associated apolipoproteins. Innate Immunity. 18(1). 171–178. 7 indexed citations
3.
Tidswell, Mark, William Tillis, Steven P. LaRosa, et al.. (2009). Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis*. Critical Care Medicine. 38(1). 72–83. 183 indexed citations
4.
5.
Lynn, Melvyn, Y. Nancy Wong, Richard Kao, et al.. (2004). Extended in Vivo Pharmacodynamic Activity of E5564 in Normal Volunteers with Experimental Endotoxemia. Journal of Pharmacology and Experimental Therapeutics. 308(1). 175–181. 32 indexed citations
6.
Kumar, Anand, Eugene Bunnell, Melvyn Lynn, et al.. (2004). Experimental Human Endotoxemia Is Associated With Depression of Load-Independent Contractility Indices. CHEST Journal. 126(3). 860–867. 30 indexed citations
7.
Lynn, Melvyn, Daniel P. Rossignol, Richard Kao, et al.. (2003). Blocking of Responses to Endotoxin by E5564 in Healthy Volunteers with Experimental Endotoxemia. The Journal of Infectious Diseases. 187(4). 631–639. 127 indexed citations
8.
Wong, Y. Nancy, Daniel P. Rossignol, Jeffrey Rose, et al.. (2003). Safety, Pharmacokinetics, and Pharmacodynamics of E5564, a Lipid A Antagonist, during an Ascending Single‐Dose Clinical Study. The Journal of Clinical Pharmacology. 43(7). 735–742. 47 indexed citations
9.
Rossignol, Daniel P. & Melvyn Lynn. (2002). Antagonism of <I>in vivo</I> and <I>ex vivo</I> response to endotoxin by E5564, a synthetic lipid A analogue. Journal of Endotoxin Research. 8(6). 483–488. 68 indexed citations
10.
Bunnell, Eugene, Melvyn Lynn, Kalim Habet, et al.. (2000). A lipid A analog, E5531, blocks the endotoxin response in human volunteers with experimental endotoxemia. Critical Care Medicine. 28(8). 2713–2720. 69 indexed citations
11.
Rose, Jeffrey, William J. Christ, Lynn D. Hawkins, et al.. (2000). Consequences of Interaction of a Lipophilic Endotoxin Antagonist with Plasma Lipoproteins. Antimicrobial Agents and Chemotherapy. 44(3). 504–510. 31 indexed citations
12.
Wasan, Kishor M., et al.. (1999). Lipoprotein Distribution of a Novel Endotoxin Antagonist, E5531, in Plasma from Human Subjects with Various Lipid Levels. Antimicrobial Agents and Chemotherapy. 43(10). 2562–2564. 20 indexed citations
13.
Neill, Darryl B., et al.. (1999). Dopamine D1/D2 agonists injected into nucleus accumbens and ventral pallidum differentially affect locomotor activity depending on site. Neuroscience. 93(4). 1349–1358. 80 indexed citations
14.
Lynn, Melvyn, Samantha Rogers, & Lawrence Friedhoff. (1997). E5531, A Lipid A Antagonist, Blocks the Response to Endotoxin in Normal Volunteers.. Shock. 7(Supplement). 5–5. 1 indexed citations
15.
Bunnell, Eugene, Alex Neumann, Melvyn Lynn, et al.. (1995). E5531, AN ENDOTOXIN ANTAGONIST, BLOCKS THE HYPERDYNAMIC AND DEPRESSANT CARDIOVASCULAR EFFECTS OF ENDOTOXIN IN HEALTHY SUBJECTS. Critical Care Medicine. 23(Supplement). A151–A151. 6 indexed citations
16.
Lanza, François, M F Rack, Melvyn Lynn, Jean‐Pierre Wolf, & Marie Sanda. (1987). An endoscopic comparison of the effects of etodolac, indomethacin, ibuprofen, naproxen, and placebo on the gastrointestinal mucosa.. PubMed. 14(2). 338–41. 68 indexed citations
17.
Undesser, K. P., Jingye Pan, Melvyn Lynn, & V. S. Bishop. (1985). Baroreflex control of sympathetic nerve activity after elevations of pressure in conscious rabbits. American Journal of Physiology-Heart and Circulatory Physiology. 248(6). H827–H834. 40 indexed citations
18.
Undesser, K. P., Melvyn Lynn, & V. S. Bishop. (1984). Rapid resetting of aortic nerves in conscious rabbits. American Journal of Physiology-Heart and Circulatory Physiology. 246(2). H302–H305. 17 indexed citations
19.
Lynn, Melvyn & Morris Solotorovsky. (1981). Chemotherapeutic Agents for Bacterial Infections. Medical Entomology and Zoology. 1 indexed citations
20.
Lynn, Melvyn, et al.. (1980). Alterations in Cardiac Function and Cardiopulmonary Blood Volume in Chronic Sodium Depletion in Dogs. Clinical Science. 59(s6). 393s–395s. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David E. Newcomb Breakdown of academic impact, for papers by S E Calvano Breakdown of academic impact, for papers by Mohammed M. Sayeed Breakdown of academic impact, for papers by Robert Hageman Breakdown of academic impact, for papers by Sally Betz Corradin Breakdown of academic impact, for papers by Hongke Zeng Breakdown of academic impact, for papers by Michela Rebsamen Breakdown of academic impact, for papers by David Cruz‐Robles Breakdown of academic impact, for papers by Hong‐Beom Bae Breakdown of academic impact, for papers by Judy A. Spitzer
Rankless by CCL
2026